Everyday Health launches virtual doctor tool

Share this article:
Everyday Health launches virtual doctor tool
Everyday Health launches virtual doctor tool
Everyday Health launched a tool allowing patients to query a video doctor by entering a symptom, and then responding to follow-up questions.

The doctor appearing in the video symptom checker is Stephen Schueler, MD, CEO and founder of DSHI Systems, the designer of the technology. The patient triage system created by the company – now present on Everyday Health's website – and has been used by the US Department of Veterans Affairs, and the University of Central Florida Student Health Services, according to DSHI's website.

When the tool opens, Schueler appears in a video, instructing consumers to enter a symptom into a blank field. Based on that initial input, Schueler guides the consumer through a number of health questions, some seemingly unrelated to the symptom, to produce a possible diagnosis. Schueler also provides a recommendation on whether an offline visit with a doctor is in order. Schueler's video segments are pre-recorded and triggered based on the consumer's text entries.  

In addition to advising patients, the site tracks occurrence rates of certain symptoms and will alert public health officials via de-identified data, on the potential for any disease outbreak.

The symptom checker has the capacity to analyze over 3,000 symptoms across all conditions and age groups, according to an Everyday Health statement. The tool is similar to a symptom checker on WebMD's website, although the latter differs in that a real doctor's image isn't present. Rather, a mannequin is present for patients to click on, to identify symptom areas. 
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.